At Novo Nordisk we are committed to discover, create and co-create
innovation to solve healthcare challenges for people living with
diabetes, obesity, cardiovascular disease, NASH, chronic kidney
disease, and blood and endocrine disorders. One way of doing this is
through our open innovation initiatives such as rewarding LabCentral
The first Novo Nordisk-sponsored Golden Tickets were awarded in
2019 to life sciences companies Cellino Biotech, Inc. and Summation
Bio. Listen to their stories.